SCHEMBL8072349

SCHEMBL8072349

C[C@@H](O)SC(=O)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8389426 1.00 TP53 (0.32) TP53
SCHEMBL17662488 0.80 NOS3 (0.33)
SCHEMBL15645910 0.78
SCHEMBL7161276 0.67
SCHEMBL7161283 0.67
SCHEMBL9144010 0.65 ALDH1A1 (0.33)
SCHEMBL5145029 0.65 ALDH1A1 (0.33)
SCHEMBL10045204 0.65
SCHEMBL24187533 0.63 ALDH1A1 (0.31)
SCHEMBL1319847 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046964-B1 TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS BY REVERSIBLE PHOSPHOTRIESTER CHARGE NEUTRALIZATION PROTECTING GROUPS UNIV CALIFORNIA (US) 2018-07-04 EP claimed
US-6124445-A PRO DRUGS FOR OLIGONUCLEOTIDES HAVING BIOREVERSIBLE PHOSPHATE BLOCKING GROUPS ISIS PHARMACEUTICALS, INC. (US) 2000-09-26 US disclosed
US-5955591-A OLIGONUCLEOTIDES HAVING BIOREVERSIBLE PHOSPHATE BLOCKING GROUPS; USED AS PRODRUGS; ANTISENSE AGENTS CENTER NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1999-09-21 US disclosed
US-5627185-A Acyclovir derivatives as antiviral agents CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1997-05-06 US disclosed
WO-1996033201-A1 ACYCLOVIR DERIVATIVES AS ANTIVIRAL AGENTS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1996-10-24 WO disclosed